Word: partings
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
...this? Partly it's owing to patient misconceptions. "Patients are concerned if they enter a clinical trial that they may be part of the unlucky group that gets the placebo or 'dummy treatment' and not the real medicine," says Dr. Bob Comis, president of the National Cancer Cooperative Groups. They think the placebo group gets no treatment at all, when in fact it gets whatever is considered the best current standard of care...
Cost shouldn't be a consideration. Most clinical trials are free to patients; some even pay their subjects. Insurance companies in the past have been reluctant to cover the nonexperimental part of the treatment, but they are starting to come around...
...thinking of hiring Achieva "not only for test prep but also to teach reading and writing skills." We hired Achieva not to supplant what our staff already does, and certainly not to rescue us, but instead to assist us in our focus on success for all students. If that part is controversial, then so be it. We are pleased with what Achieva has done so far, and we will continue to have its people work with us for as long as they help us to show continued improvement for our students. FRED DE FUNIAK, PRINCIPAL Silver Creek High School...
...News's 20/20 report [PERSONAL TIME: YOUR HEALTH, Nov. 1]. Those of us who spent four months investigating the safety of cell phones read Smith's column with disbelief. How could the description of our report be so inaccurate? We questioned whether Smith had even seen our two-part, 24-min. broadcast. He wrote that he was "startled by the possibility that ABC could have uncovered a smoking gun in a medical controversy that has been simmering unresolved for years." But we specifically reported, "There is no smoking gun." This is just one example of how Smith distorted our report...
...counter, what about Claritin patients--who pay as much as $2.66 a dose instead of the 50[cents] or less they would pay, analysts figure, if a generic version of the drug were available? If the patent expires on time, according to a University of Minnesota study funded in part by the generic-drug industry, consumers could save $7.33 billion over five years. Those arguments helped persuade Montana G.O.P. Senator Conrad Burns, who faces a tough re-election fight next year, to drop his support for the bill this fall, saying he wanted no part in forcing millions of Americans...